Investors have gotten their money's worth out of Boston Scientific's (NYSE: BSX ) stock lately. Shares of the medical device maker have surged by more than 30% in the past six months alone, rising higher despite the company's troubles. Sales have fallen into a slump at Boston Scientific, led lower by the company's cardiac rhythm management, or CRM, business, which produces everything from pacemakers to implantable defibrillators. This is an industry on the decline�--�Medtronic (NYSE: MDT ) , a leader in the medical device field, has seen its own CRM sales slump in recent quarters, while Boston Sci rival St. Jude Medical (NYSE: STJ ) has similarly had its top line hammered by its CRM division's falling revenue.
Boston Scientific is more than just a cardiovascular device maker, however -- and its smaller, growing divisions invite hope for the company's future despite the slump in its core business. In this video, Motley Fool contributor Dan Carroll and health care analyst Max Macaluso discuss one of Boston Scientific's hot growing businesses and why investors should pay attention to the company's upcoming earnings report to see whether it's making the right moves to turn around its lagging sales.
Top Trucking Stocks To Buy Right Now: Cardtronics Inc.(CATM)
Cardtronics, Inc., together with its subsidiaries, provides automated consumer financial services through its network of automated teller machines (ATMs) and multi-function financial services kiosks. As of December 31, 2011, it offered services to approximately 52,900 devices across its portfolio, which included approximately 46,000 devices located in 50 states of the United States, as well as in the U.S. territories of Puerto Rico and the U.S. Virgin Islands; approximately 3,500 devices throughout the United Kingdom; approximately 2,800 devices throughout Mexico; and approximately 600 devices in Canada. The company also deployed approximately 2,200 multi-function financial services kiosks in the United States. Its ATMs and financial services kiosks offer cash dispensing and bank account balance inquiry services, as well as other consumer financial services, including bill payments, check cashing, remote deposit capture, and money transfer services. In addition, the compan y provides various forms of managed service solution, including monitoring, maintenance, cash management, customer service, and transaction processing services. Further, it partners with national financial institutions to brand its ATMs and financial services kiosks with their logos. As of December 31, 2011, the company had approximately 15,400 company-owned ATMs under contract with financial institutions to place their logos on those machines. Additionally, it provides financial institutions with surcharge-free program through its Allpoint network, as well as owns and operates an electronic funds transfer transaction processing platform that provides transaction processing services to its network of ATMs and financial services kiosks, and ATMs owned and operated by third parties. The company was formerly known as Cardtronics Group, Inc. and changed its name to Cardtronics, Inc. in January 2004. Cardtronics, Inc. was founded in 1989 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Cardtronics (Nasdaq: CATM ) , whose recent revenue and earnings are plotted below.
Best Healthcare Technology Companies To Invest In Right Now: Covanta Holding Corp (CVA)
Covanta Holding Corporation (Covanta), incorporated in April 16, 1992, is a holding company. The Company is a owner and operator of infrastructure for the conversion of waste to energy ( energy-from-waste or EfW), as well as other waste disposal and renewable energy production businesses. Covanta conduct all of its operations through subsidiaries which are engaged predominantly in the businesses of waste and energy services. The Company has one segment which is Americas and consists of waste and energy services operations primarily in the United States and Canada. The Company owns and holds interests in energy-from-waste facilities in China and Italy. The Company also has investments in subsidiaries engaged in insurance operations in California, primarily in property and casualty insurance. In 2011, it sold two landfill gas projects located in California. In May 2011, it acquired a metals processing facility located on its Dade energy-from-waste facility site.
As of December 31, 2011, it owned 85% interest of Taixing Covanta Yanjiang Cogeneration Co., Ltd. It operates and maintains the energy-from-waste facility located in and owned by the City and County of Honolulu, Hawaii. In December 2011, the Company amended the waste disposal agreement with the Union County Utilities Authority to extend their terms from 2023 to 2031 and to increase the Union County Utilities Authority�� waste disposal commitment. The Company�� EfW facilities earn revenue from both the disposal of waste and the generation of electricity, generally under long-term contracts, as well as from the sale of metal recovered during the energy-from-waste process. In the Americas, it processes approximately 19 million tons of solid waste annually. In total, these assets produce over 10 million megawatt hours of baseload electricity annually. The Company operates and/or has ownership positions in 46 energy-from-waste facilities, which are primarily located in North America, and 15 additional energy generation facilities, i! ncluding other renewable energy production facilities in North America (wood biomass and hydroelectric). The Company also operates a waste management infrastructure that is complementary to its core EfW business.
Energy-From-Waste Projects
Energy-from-waste projects have two purposes: to provide waste disposal services, typically to municipal clients who sponsor the projects, and to use that waste as a fuel source to generate renewable energy. The electricity or steam generated by the projects is generally sold to local utilities or industrial customers. The projects are capable of providing waste disposal services and generating electricity or steam. The Company provides these waste disposal services and sell the electricity and steam generated under contracts, which expire on various dates between 2012 and 2034. Many of its service contracts may be renewed for varying periods of time, at the option of the municipal client.
Tehe Company�� energy-from-waste projects generate revenue from three main sources: fees charged for operating projects or processing waste received; the sale of electricity and/or steam, and the sale of ferrous and non-ferrous metals that are recycled as part of the energy-from-waste process. Its customers for waste disposal or facility operations are principally municipal entities, though it also markets disposal capacity at certain facilities to commercial and special waste customers. Its facilities sell energy primarily to utilities at contracted rates or, in situations where a contract is not in place, at prevailing market rates in regional markets (primarily PJM, NEPOOL and NYISO in the Northeastern United States).
The Company operates, and in some cases has ownership interests in, transfer stations and landfills, which generate revenue from ash disposal fees or operating fees. In addition, it owns, and in some cases operates, other renewable energy projects in the Americas segment, which generate electricity from wood wast! e (biomas! s) and hydroelectric resources. The electricity from these other renewable energy projects is sold to utilities under contracts or into the regional power pool at short-term rates. For these projects, it receives revenue from sales of energy, capacity and/or cash from equity distributions and additional value from the sale of renewable energy credits.
The Company operates energy-from-waste projects in 16 states and one Canadian province, and are constructing an energy-from-waste project in a second Canadian province. Most of its energy-from-waste projects were developed and structured contractually as part of competitive procurement processes conducted by municipal entities. Its EfW projects can generally be divided into three categories, based on the applicable contract structure at a project: Tip Fee projects, Service Fee projects that the Company owns, and Service Fee projects that it do not own but operate on behalf of a municipal owner. At Tip Fee projects, it receives a per-ton fee for processing waste, and it typically retain all of the revenue generated from energy and recycled metal sales. The Company generally owns or leases the Tip Fee facilities. At Service Fee projects, it typically charge a fixed fee for operating the facility, and the facility capacity is dedicated either primarily or exclusively to the host community client, which also retains the majority of any revenue generated from energy and recycled metal sales. The Company also owns and/or operates 13 transfer stations and four ash landfills in the northeast United States, which it utilizes to supplement and manage more efficiently the fuel and ash disposal requirements at its energy-from-waste operations. The Company provides waste procurement services to its waste disposal and transfer facilities which have available capacity to receive waste.
Biomass Projects
The Company owns and operates seven wood-fired generation facilities and have a 55% interest in a partnership which owns another w! ood-fired! generation facility. The Company�� six facilities are located in California, and two are located in Maine. The combined gross energy output from these facilities is 191 megawatts. The Company generates income from its biomass facilities from sales of electricity, capacity, and where available, additional value from the sale of renewable energy credits. These facilities sell their energy output into local power pools or to local utilities at rates that are either fixed or float with the market.
Hydroelectric
The Company owns a 50% interest in two small run-of-river hydroelectric facilities located in the State of Washington, which sells energy and capacity to Puget Sound Energy under long-term energy contracts. The Company has a nominal investment in two hydroelectric facilities in Costa Rica.
Energy-From-Waste
The Company and Chongqing Iron & Steel Company (Group) Ltd. entered into an agreement to build, own, and operate a 1,800 metric ton per day energy-from-waste facility for Chengdu Municipality in Sichuan Province, People�� Republic of China. The Company also executed a 25 year waste concession agreement for this project. In connection with this project, it acquired a 49% interest in the project company. Construction commenced in 2009 and the facility began processing waste during the year ended December 31, 2011. The electrical output from these projects is sold at governmentally established preferential rates under short-term arrangements with local power bureaus. As of December 31, 2011, the Company owned 85% of Taixing Covanta Yanjiang Cogeneration Co., Ltd. which, in 2009, entered into a 25 year concession agreement and waste supply agreements to build, own and operate a 350 metric tons per day energy-from-waste facility for Taixing Municipality, in Jiangsu Province, People�� Republic of China. The Company will continue to operate its coal-fired facility.
The Company owns a 40% interest in Chongqing Sanfeng Covanta Environ! mental In! dustry Co., Ltd. (Sanfeng), a company located in Chongqing Municipality, People�� Republic of China. Sanfeng is engaged in the business of owning and operating energy-from-waste projects, providing design and engineering, procurement, construction services and equipment sales for energy-from-waste facilities in China. Sanfeng owns minority interests in two 1,200 metric tons per day, 24 megawatts mass-burn energy-from-waste projects (Fuzhou project and Tongqing project), and has a contract to operate the Chengdu project. Chongqing Iron & Steel Group Environmental Investment Co. Ltd., a wholly owned subsidiary of Chongqing Iron & Steel Company (Group) Ltd., holds the remaining 60% interest in Sanfeng. The solid waste supply for the projects comes from municipalities under long-term contracts. The municipalities also have the obligation to coordinate the purchase of power from the facilities as part of the long-term contracts for waste disposal. The electrical output from these projects is sold at governmentally established preferential rates under short-term arrangements with local power bureaus.
The Company owns a 13% interest in a 500 metric tons per day, 18 megawatts mass-burn energy-from-waste project at Trezzo sull��dda in the Lombardy Region of Italy. The project is operated by Ambiente 2000 S.r.l., in which the Company owns 40%. The solid waste supply for the project comes from municipalities and privately-owned waste haulers under long-term contracts. The electrical output from the Trezzo project is sold at governmentally established preferential rates under a long-term purchase contract to Italy�� state-owned electricity grid operator, Gestore della Rete di Trasmissione Nazionale S.p.A.
Independent Power Projects
The Company has a majority interest in a 24 megawatts (gross) coal-fired cogeneration facility in Taixing City, Jiangsu Province, People�� Republic of China. The project entity, in which it holds a majority interest, operates this project. T! he party ! holding a minority position in the project is an affiliate of the local municipal government. While the steam produced at this project is focused to be sold under a long-term contract to its industrial host, in practice, steam has been sold on a short-term basis to either local industries or the industrial host, in each case at varying rates and quantities. The electric power is sold at an average grid rate to a subsidiary of the provincial power bureau.
Advisors' Opinion:- [By Dan Caplinger]
More recently, Waste Management has looked for further innovations in its business. Its landfills give it two potential energy sources, one from the gases that landfills produce, and a second from incinerating garbage to produce electricity. Rival Covanta (NYSE: CVA ) pioneered the waste-to-energy movement and is the leading company in the space, but both Waste Management and No. 2 landfill operator Republic Services (NYSE: RSG ) have pressed hard at building up their own renewable energy businesses. Moreover, Waste Management's partnership with Clean Energy Fuels (NASDAQ: CLNE ) to convert its hauling trucks to use natural gas brings the trash giant's renewable energy efforts full-circle.
- [By Marc Bastow]
Waste disposal and energy management holding company Covanta (CVA) raised its quarterly dividend 9% to 18 cents per share, payable April 2 to shareholders of record as of March 26.
CVA Dividend Yield: 4.10% - [By Seth Jayson]
Covanta Holding (NYSE: CVA ) reported earnings on July 17. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), Covanta Holding beat expectations on revenues and beat expectations on earnings per share.
Best Healthcare Technology Companies To Invest In Right Now: Freeport-McMoran Copper & Gold Inc.(FCX)
Freeport-McMoRan Copper & Gold Inc. engages in the exploration, mining, and production of mineral resources. The company primarily explores for copper, gold, molybdenum, silver, and cobalt. It holds interests in various properties, located in North and South America; the Grasberg minerals district in Indonesia; and the Tenke Fungurume minerals district in the Democratic Republic of Congo. As of December 31, 2010, the company?s consolidated recoverable proven and probable reserves totaled 120.5 billion pounds of copper, 35.5 million ounces of gold, 3.39 billion pounds of molybdenum, 325.0 million ounces of silver, and 0.75 billion pounds of cobalt. The company was founded in 1987 and is headquartered in Phoenix, Arizona.
Advisors' Opinion:- [By Rich Smith]
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature a pair of new buy ratings for large-caps Intel (NASDAQ: INTC ) and Freeport-McMoRan (NYSE: FCX ) . But the news isn't all good.
- [By Roberto Pedone]
One integrated mining player that insiders are buying up a huge amount of stock in here is Freeport-McMoRan Copper & Gold (FCX), which deals in the mining of copper, gold and molybdenum. Insiders are buying this stock into weakness, since shares are off by 17.5% so far in 2013.
Freeport-McMoRan Copper & Gold has a market cap of $27.5 billion and an enterprise value of $50.2 billion. This stock trades at a cheap valuation, with a trailing price-to-earnings of 9.95 and a forward price-to-earnings of 8.92. Its estimated growth rate for this year is -23.9%, and for next year it's pegged at 27.8%. This is not a cash-rich company, since the total cash position on its balance sheet is $3.29 billion and its total debt is $21.22 billion. This stock currently sports a dividend yield of 4.3%.
A director just bought 517,350 shares, or about $14.82 million worth of stock, at $28.64 per share.
From a technical perspective, FCX is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending over the last five month, with shares dropping from its high of $33 to its recent low of $26.07 a share. Shares of FCX recently formed a double bottom chart pattern at $26.04 to $26.07 a share. Following that bottom, this stock has trended higher to $30.14 a share, but it just failed to hold above its 50-day at $28.60 a share.
If you're bullish on FCX, then I would look for long-biased trades as long as this stock is trending above some near-term support levels at $27 to $26 and then once it takes out its 50-day at $28.60 a share with high volume. Look for a sustained move or close above its 50-day with volume that hits near or above its three-month average action of 17.31 million shares. If we get that move soon, then FCX will set up to re-test or possibly take out its next major overhead resistance levels at $30.14 to $32 a share.
Best Healthcare Technology Companies To Invest In Right Now: Changyou.com Limited(CYOU)
Changyou.com Limited develops and operates online games in the People?s Republic of China. It involves in the development, operation, and licensing of massively multi-player online role-playing games (MMORPGs), which are interactive online games that might be played simultaneously by various game players. The company operates seven MMORPGs that include its in house developed Tian Long Ba Bu; and licensed Blade Online, Blade Hero 2, Da Hua Shui Hu, Zhong Hua Ying Xiong, Immortal Faith, and San Jie Qi Yuan. As of December 31, 2010, Changyou?s games in China had approximately 111.4 million aggregate registered accounts; 1.0 million aggregate peak concurrent users; and 2.7 million aggregate active paying accounts. The company was founded in 2003 and is based in Beijing, the People?s Republic of China. Changyou.com Limited is a subsidiary of Sohu.com Inc.
Advisors' Opinion:- [By Yiannis Mostrous]
Changyou.com (CYOU)
A subsidiary of Internet portal Sohu.com, video game developer Changyou.com specializes in massively multiplayer online role-playing games (MMORPG).
- [By Kevin Chen]
To be fair, these revenues come from their stake in game company Changyou (NASDAQ: CYOU ) . Because Sohu owns a majority stake in Changyou, Sohu must consolidate all financials into its statements -- even as Changyou is independently listed on stock exchanges. Whatever the case, Sohu actually created Changyou -- it started as a business unit in 2003, then was spun out in 2007. In any case, Sohu should do some serious soul-searching.
Best Healthcare Technology Companies To Invest In Right Now: Urban Outfitters Inc.(URBN)
Urban Outfitters Inc. operates lifestyle specialty retail stores under the Urban Outfitters, Anthropologie, Free People, Terrain, and BHLDN brand names in the United States, Canada, and Europe. Its Urban Outfitters stores sell women?s and men?s fashion apparel, footwear, accessories, and gifts, as well as apartment wares, such as rugs, pillows, shower curtains, books, candles, and novelties to young adults aged 18 to 28; and Anthropologie stores provide women?s casual apparel and accessories, shoes, gifts, and decorative items, as well as home furnishings, including furniture, rugs, lighting, antiques, table top items, and bedding to women aged 28 to 45. The company?s Free People stores primarily offer Free People branded merchandise mix of casual women?s apparel, intimates, shoes, accessories, and gifts to young contemporary women aged 25 to 30; Terrain store provides lifestyle home and garden products, antiques, live plants, flowers, wellness products, and accessori es, as well as landscape and design service solutions; and BHLDN store offers a range of weeding collections consisting of wedding gowns, bridesmaid frocks, party dresses, assorted jewelry, headpieces, footwear, lingerie, and decorations. As of January 31, 2012, it operated 197 Urban Outfitters stores, 168 Anthropologie stores, 62 Free People stores, 1 Terrain garden center, and 1 BHLDN store. The company also operates a wholesale business under the Free People brand name that distributes apparel to other retailers and department stores in the United States. In addition, it markets its brands directly to consumers through its e-commerce Websites, including urbanoutfitters.com, anthropologie.com, freepeople.com, urbanoutfitters.co.uk, urbanoutfitters.de, urbanoutfitters.fr, anthropologie.eu, shopterrain.com, and bhldn.com, as well as through its Urban Outfitters, Anthropologie, and Free People catalogs. The company was founded in 1970 and is based in Philadelphia, Pennsylvani a.
Advisors' Opinion:- [By Alyce Lomax]
All in the family
For several years, activist shareholders have pushed for board diversity at Urban Outfitters (NASDAQ: URBN ) . Although the retailer caters to a heck of a lot of female customers, not one woman has served on the company's board of directors.
Best Healthcare Technology Companies To Invest In Right Now: Onconova Therapeutics Inc (ONTX)
Onconova Therapeutics, Inc. (Onconova), incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways, which promote cancer. It has three clinical-stage product candidates and six preclinical programs. Its preclinical pipeline includes six programs, which target kinases, cellular metabolism or division.
Rigosertib
Rigosertib, the Company�� product candidate, is being tested in a range of ongoing Phase-II and Phase-III clinical trials. The Company is conducting a pivotal phase-III trial of rigosertib under a Special Protocol Assessment (SPA), from the United States Food and Drug Administration (FDA), for higher risk myelodysplastic syndromes (MDS). The Company is also evaluating rigosertib in a Phase-III trial for metastatic pancreatic cancer, in two Phase-II trials for transfusion-dependent lower risk MDS, and in a Phase-II trial for head and neck cancers. Rigosertib has been granted orphan drug status for MDS in both the United States and Europe, as well as orphan drug status for pancreatic cancer in the United States. Baxter Healthcare SA (Baxter), a subsidiary of Baxter International Inc., has commercialization rights for rigosertib in Europe and SymBio Pharmaceuticals Limited (SymBio), has commercialization rights in Japan and Korea. Rigosertib is an inhibitor of two cellular signaling pathways: phosphoinositide 3-kinase (PI3K), and polo-like kinase (PLK), both of which are frequently over-active in cancer cells. By inhibiting the PI3K pathway in cancer cells, rigosertib promotes tumor cell apoptosis, or programmed cell death. It is testing both intravenous and oral formulations of rigosertib, referred to as rigosertib IV and rigosertib Oral, in clinical trials.
ON 013105
The Company�� clinical-stage product candidate, ON 013105, is i! n a Phase I trial in patients with relapsed or refractory lymphoma, including an aggressive form of non-Hodgkin's lymphoma identified as mantle cell lymphoma (MCL), and acute lymphoid leukemia (ALL). ON 013105 suppresses the accumulation of cyclin D1 in cancer cells.
Recilisib
The Company�� clinical-stage product candidate, recilisib, is being developed in collaboration with the United States Department of Defense (DoD), for acute radiation syndromes (ARS). The Company has completed four Phase-I trials to evaluate the safety and pharmacokinetics of recilisib in healthy human adult subjects using both subcutaneous and oral formulations, referred to as recilisib SC and recilisib Oral.
Preclinical Programs
The Company�� ON 1231320 is a specific inhibitor of Polo-like Kinase 2 (PLK2), and in preclinical studies, it induced mitotic arrest and reduced tumor burden in mice injected subcutaneously with colon tumor and triple-negative breast cancer cells. The Company�� ON 123300 inhibits the activity of two kinases, cyclin-dependent kinase 4 (CDK4), and AMP-activated protein kinase 5 (ARK5). Its ON 108600 is a dual inhibitor of two growth-regulatory kinases. Cyclin-dependent kinase 9 is over expressed in several cancers, including leukemias and lymphomas. Casein kinase 2 is overexpressed in a range of tumor types. ON 044580 inhibits mutant forms of the two target kinases, including Janus Kinase 2 (JAK2) and imatinib-resistant Bcr-Abl Kinase (Bcr-Abl). Its ON 24 compounds cause tubulin to depolymerize, inducing mitotic arrest in cultured tumor cell lines. Its ON 146040 inhibits the growth of a range of blood cancer cell lines, including Burkitt's lymphoma, MCL, multiple myeloma and chronic myeloid leukemia.
The Company competes with Eisai Inc., Celgene Corporation, Genentech, Inc., Cell Therapeutics, Inc., Cyclacel Pharmaceuticals, Inc., Telik, Inc., Spectrum Pharmaceuticals, Inc., Astex, Array BioPharma Inc., Astellas Pharma, Inc., Threshold! Pharmace! uticals, Inc., Pharmacyclics Inc., Soligenix, Inc., Cellerant Therapeutics, Inc. and Cleveland BioLabs, Inc.
Advisors' Opinion:- [By Roberto Pedone]
Onconova Therapeutics (ONTX), a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. This stock closed up 2.5% to $5.15 in Thursday's trading session.
Thursday's Range: $4.97-$5.19
52-Week Range: $4.10-$31.13
Thursday's Volume: 132,000
Three-Month Average Volume: 216,102From a technical perspective, ONTX trended modestly higher here with lighter-than-average volume. This stock has been uptrending over the last few weeks, with shares moving higher from its low of $4.10 to its recent high of $5.52. During that uptrend, shares of ONTX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ONTX within range of triggering a near-term breakout trade. That trade will hit if ONTX manages to take out Thursday's intraday high of $5.19 to some more key overhead resistance at $5.52 with high volume.
Traders should now look for long-biased trades in ONTX as long as it's trending above some near-term support levels at $4.80 or at $4.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 216,102 shares. If that breakout gets underway soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $5.83 to $6.27. Any high-volume move above those levels will then give ONTX a chance to tag $7.
- [By Roberto Pedone]
One under-$10 clinical-state biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Onconova Therapeutics (ONTX), which focuses on discovering and developing small molecule drug candidates to treat cancer. This stock has been destroyed by the short-sellers so far in 2014, with shares off sharply by 56%.
If you glance at the chart for Onconova Therapeutics, you'll notice that this stock has been trending sideways and consolidating right below its 50-day moving average for the last few weeks. This consolidation pattern is occurring right after shares of ONTX recently spiked sharply higher from its low of $4.10 to its high of $5.52 a share. Shares of ONTX are now trending within range of breaking out of that consolidation pattern and potentially heading higher.
Traders should now look for long-biased trades in ONTX if it manages to break out above its 50-day moving average of $5.09 a share and then once it takes out some more key overhead resistance levels at $5.24 to $5.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 203,756 shares. If that breakout triggers soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $6.27 to $7 a share.
Traders can look to buy ONTX off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.75 to right around $4.50 a share. One can also buy ONTX off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By gurujx]
Onconova Therapeutics Inc (ONTX) Reached the 3-year Low of $4.18
The prices of Onconova Therapeutics Inc (ONTX) shares have declined to close to the 3-year low of $4.18, which is 86.8% off the 3-year high of $31.13.
No comments:
Post a Comment